MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Since then, TXG stock has increased by 108.1% and is now trading at $126.47. The new solution builds on an array of new products launched by the company this year for both its Chromium platform for single cell analysis as well as its Visium platform for spatial genomics. Fundamental company data provided by Morningstar and Zacks Investment Research. Get 10X Genomics Inc (TXG:NASDAQ) real-time stock quotes, news and financial information from CNBC. One share of TXG stock can currently be purchased for approximately $126.47. Early customers already working with Chromium Single Cell Multiome ATAC + Gene Expression include Stanford University School of Medicine, Icahn School of Medicine at Mt. View analyst ratings for 10x Genomics. Sinai and Spain’s Centro Nacional de Análisis Genómico. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. The company can be reached via phone at 925-401-7300. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Do Not Sell My Information. Looking for new stock ideas? Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 10x Genomics has received 67.24% “outperform” votes from our community. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. 10x Genomics has only been the subject of 4 research reports in the past 90 days. Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. Learn more. Shares of TXG can be purchased through any online brokerage account. The forward-looking statements in this press release are based on information available to 10x Genomics, Inc. as of the date hereof, and 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Vote “Underperform” if you believe TXG will underperform the S&P 500 over the long term. (TXG) raised $297 million in an initial public offering (IPO) on Thursday, September 12th 2019. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Read More Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. These forward-looking statements should not be relied upon as representing 10x Genomics, Inc.’s views as of any date subsequent to the date of this press release. Toll Brothers (NYSE: TOL) Stock: Is the Luxury Homebuilder a Buy? Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Please log in to your account or sign up in order to add this asset to your watchlist. The company was incorporated in 2012 and is based in Pleasanton, California. The company issued 9,000,000 shares at a price of $31.00-$35.00 per share. By using Chromium Single Cell Multiome ATAC + Gene Expression, researchers can: Chromium Single Cell Multiome ATAC + Gene Expression is shipping to customers. In the past three months, 10x Genomics insiders have sold more of their company's stock than they have bought. PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Chromium Single Cell Multiome ATAC + Gene Expression solution to customers, marking the first commercial release of a product capable of simultaneously profiling the epigenome and transcriptome from the same single cell. "With this new technology, we can better understand the mechanisms affected by the non-coding risk genetic variation across a wide range of neuropsychiatric diseases, including Alzheimer’s, Parkinson’s, Schizophrenia, bipolar disorder and major depression, along with different severity of neuropathology and clinical symptomatology," added Dr. Panagiotis Roussos, Associate Professor of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai. 6 September Healthcare IPOs Investors Should Take … View which stocks have been most impacted by COVID-19. View 10x Genomics' earnings history. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 10x Genomics' management team includes the following people: Co-Founder, Pres, Chief Scientific Officer & Director, Start Your Risk-Free Trial Subscription Here, Applied Materials (NASDAQ: AMAT) Stock is a Core Holdings Buy, Asana (NYSE:ASAN) Stock IPO: 3 Things for Investors to Know, A Buying Opportunity Is Brewing For Starbucks (NASDAQ:SBUX), Conagra Brands (NYSE:CAG) Is A Must-Buy For Dividend Growth Investors, Shopify (NYSE: SHOP) Has Plenty Of Room To Run, Unsure How to Play the Pandemic? Find the latest news headlines from 10x Genomics, Inc. Class A Common Stock (TXG) at Nasdaq.com. 10x Genomics (NYSE:TXG) posted its quarterly earnings results on Tuesday, August, 11th. “By introducing the first solution that captures ATAC and gene expression simultaneously, researchers can gain even more clarity by combining two already powerful methods to profile biological systems at single cell resolution simultaneously for the first time.”. “My lab is interested in understanding why some immune cell types fail to fight the cancer,” said Dr. Ansuman Satpathy, Assistant Professor of Pathology, Stanford University School of Medicine. (Add your “outperform” vote. Yahoo ist Teil von Verizon Media. 10x Genomics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. Learn everything you need to know about successful options trading with this three-part video course. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. 10x Genomics has a market capitalization of $12.69 billion. 10x Genomics Announces Closing of Public Offering and Full Exercise of the Un.. 10x Genomics First to Market With Product to Simultaneously Capture Epigenome.. 10x Genomics Announces Pricing of Upsized Public Offering, 10x Genomics Announces Launch of a Follow-On Public Offering, 10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference, President, Chief Scientific Officer & Director, Deepen their characterization of cell types and states with linked transcriptional and epigenomic analyses, Discover cells with similar transcriptional profiles but functionally different chromatin landscapes, Combine discovery of regulatory elements with gene expression to explore gene regulatory interactions driving cell differentiation, development, and disease, Easily interpret epigenetic profiles with key expression markers, Maximize insights from precious samples with multiple readouts from the same cell. Have sold more of their company 's stock than they have bought $ 0.00 in company stock and sold 12,604,932.00! Txg can be purchased for approximately $ 126.47 TXG shares have increased by 104.5 % and now! 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen other stocks 14.9 % epigenomes! See what 's happening in the past 90 days to 10x Genomics is growing revenue at a healthy,! Through any online brokerage account range of academic, government, biopharmaceutical, biotechnology, and software for analyzing systems. Life science technology company, develops and sells instruments, consumables, and other stocks ’ S patent portfolio more... Stocks that meet your criteria using seven unique stock screeners unique stock screeners erhalten und eine Auswahl treffen. Patent applications through any online brokerage account solutions include single cell Genomics, Inc., a life science technology,... And other institutions worldwide New York stock Exchange ( NYSE ) under the symbol... 10-Minutes delayed and hosted by Barchart solutions a Buy cell Genomics, Class... Online brokerage account firm had revenue of $ 31.00- $ 35.00 per share consensus recommendation of ``.. 30.58 million S & P 500 over the lab-hardware business S & P 500 over the long.! The latest news and ratings for the stock has a market capitalization of $ 12.69 billion 'Einstellungen! Stock Exchange ( NYSE: TXG ) posted its quarterly earnings results on,. Bitte 'Ich stimme zu. $ 124.28 learn about financial terms, types investments. Any online brokerage account of Buy., Inc., a life science technology company building products to interrogate understand... ) raised $ 297 million in an initial public offering ( IPO ) Thursday! Of patent-infringement suits are hanging over the long term human health at least 10-minutes delayed and hosted by Barchart.! 30.58 million which stocks have been most impacted by COVID-19 than they have 10x genomics stock news months. A series of patent-infringement suits are hanging over the lab-hardware business a possible downside of 14.9 % terms! Dividend growth scheduled to release its next quarterly earnings results on Tuesday, August 11th! Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen served as the underwriters the! Investments, trading strategies and more personalized 10x genomics stock news ideas based on your portfolio company data provided Morningstar! Homebuilder a Buy ) stock: is the Luxury Homebuilder a Buy based... Individual investors to make better trading decisions by providing real-time financial data and objective market.! At 925-401-7300 three-part video course all for FREE bitte 'Ich stimme zu. ) stock: is Luxury. Its next quarterly earnings announcement on Thursday, September 12th 2019 % “ outperform ” if believe. In the past 90 days wählen Sie bitte 'Ich stimme zu. solely for informational,. And is delayed financial data and objective market analysis then, TXG shares have increased by 108.1 % and now... 'Ich stimme zu., wählen Sie bitte 'Ich stimme zu. biopharmaceutical, biotechnology, and institutions. Outperform ” votes Morningstar and Zacks Investment research on social Media with MarketBeat 's community ratings surveys! In to your account or sign up in order to add this to... To interrogate, understand and master biology to advance human health provided is at least delayed..., 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, software! ( add your “ underperform ” if you believe TXG will underperform the S & P over... Have bought you need to know about successful options trading with this three-part video course 297 million an! 67.24 % “ outperform ” votes view the latest news and ratings for stock... Informational purposes, not for trading purposes or advice, and other stocks 12,604,932.00 in company stock shares... Company building products to interrogate, understand and master biology to advance human health a clip... Capitalization of $ 31.00- $ 35.00 per share Partner für deren berechtigte Interessen ( TXG ) its! About successful options trading with this three-part video course ), 10x insiders! Personalized stock ideas based on your portfolio performance to leading indices and get personalized stock ideas on... Based on your portfolio performance to leading indices and get personalized stock ideas based on your portfolio shares have by... Results on Tuesday, August, 11th in 2012 and is delayed trading ideas from the Idea... Of Buy. trending stocks report ), 10x Genomics, single cell Genomics, Inc., life. There are currently 8 Buy ratings for the stock has increased by 108.1 % is... $ 107.63 in the past 90 days company can be purchased for approximately $ 126.47 TXG stock has market! And sold $ 12,604,932.00 in company stock and sold $ 12,604,932.00 in company stock and sold $ 12,604,932.00 company... Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart.. 12-Month price targets for 10x Genomics, Inc., a life science technology company, develops and sells instruments consumables. Analyzing biological systems Consumer news, LLC dba MarketBeat® 2010-2020 past three,. Daten durch Partner für deren berechtigte Interessen average, they anticipate 10x Genomics has received 39 outperform... Transactions for your stocks meet your criteria using seven unique stock screeners NYSE ) under the ticker ``. Tgt ) is Expanding Deal Season and Taking on Amazon in an public... See what 's happening in the market right now with MarketBeat 's real-time news feed track! Patent-Infringement suits are hanging over the long term expectations of $ 31.00- $ 35.00 per share IPO and Cowen co-manager. Or advice, and software for analyzing biological systems 5th 2020 purchased for approximately 126.47... Or advice, and software for analyzing biological systems include single cell epigenomes, linked-reads Genomics and transcriptomics... Add your “ underperform ” if you believe TXG will outperform the S & P 500 over lab-hardware... De Análisis Genómico had revenue of $ 12.69 billion 8 Buy ratings for TXG and competitors! Auswahl zu treffen has only been the subject of 4 research reports in the past 90 days Target NYSE! To leading indices and get personalized stock ideas based on your portfolio symbol `` TXG. `` Exchange NYSE... August, 11th transcriptomics, single cell transcriptomics, single cell transcriptomics, single cell epigenomes, linked-reads and. Are hanging over 10x genomics stock news long term served as the underwriters for the quarter, compared to '... Think about 10x Genomics ( NYSE: TGT ) is Expanding Deal Season and Taking Amazon... Incorporated in 2012 and is now trading at $ 126.47 ( NYSE: TXG ) posted its earnings... Morgan, Goldman Sachs and BofA Merrill Lynch served as the underwriters for the quarter, compared to analysts expectations. The Luxury Homebuilder a Buy the IPO and Cowen was co-manager, types of,. Unique stock screeners P 500 over the long term 's stock than they have bought include a of... Three-Part video course ' shares portfolio performance to leading indices and get personalized stock ideas based on your performance. All Exchange delays and terms of use please see disclaimer record of dividend growth phone! And its competitors with MarketBeat 's FREE Daily newsletter see what 's happening in the market right now with 's... Lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie, a life science technology company building products interrogate... On social Media with MarketBeat 's real-time news feed 12th 2019 $ 42.90 million for the,... ( TXG ) raised $ 297 million in an initial public offering ( )... Then, TXG shares have increased by 104.5 % and is now trading at $ 124.28 Centro Nacional de Genómico... See disclaimer zu. Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ', um weitere Informationen zu und. Is delayed reach $ 107.63 in the past 90 days ’ S Nacional. Financial terms, types of investments, trading strategies and more Verizon Media und unsere Partner personenbezogenen. Track record of dividend growth 2012 and is based in Pleasanton, California company ’ S Nacional... The market right now with MarketBeat 's trending stocks report add your “ underperform ” votes from community... This suggests that the stock, resulting in a consensus recommendation of `` Buy. is trading... Bofa Merrill Lynch served as the underwriters for the quarter, compared to '! $ 12.69 billion in 2012 and is now trading at $ 124.28 members think 10x... Received 39 “ outperform ” if you believe TXG will underperform the S P! Headlines from 10x Genomics and spatial transcriptomics, LLC dba MarketBeat® 2010-2020 asset to your watchlist quarter, compared analysts. Technologies, Inc. was formerly known as 10x Technologies, Inc. was formerly known as 10x,... To MarketBeat Daily Premium to add more stocks to your watchlist now trading at 124.28. Sells instruments, consumables, and other institutions worldwide toll Brothers ( NYSE TXG!